Quick Takeaways
- Dipan Patel filed SCHEDULE 13D/A for Amneal Pharmaceuticals, Inc. Class A Common Stock, par value $0.01 (AMRX).
- Disclosed ownership: 5.4%.
- Date of event: 31 Dec 2025.
Dipan Patel - 31 Dec 2025 SCHEDULE 13D/A Report for Amneal Pharmaceuticals, Inc. Class A Common Stock, par value $0.01 (AMRX)
- Filing Manager
- Dipan Patel
- Reporting Manager
- Patel Dipan
- Symbol
- AMRX
- Shares outstanding
- 313,041,907 shares
- Disclosed Ownership
- 16,904,263 shares
- Ownership
- 5.4%
- Form type
- SCHEDULE 13D/A
- Filing time
- 26 Mar 2026, 18:23:15 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 06 Oct 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Dipan Patel disclosed 5.4% ownership in Amneal Pharmaceuticals, Inc. Class A Common Stock, par value $0.01 (AMRX) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 06 Oct 2025.
- Current filing was accepted on 26 Mar 2026, 18:23.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Patel Dipan | 5.4% | 16,904,263 | 16,904,263 | 0 | Dipan Patel | Patel Dipan | 0001745437 |